Michael J. Warmuth, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 24,636 shares at $39.01 ($967K) on 2014-03-03, disclosed to the SEC on 2014-03-04.
Scheduled sale ($967k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.79 | 8,152 | $324K | 33.5% |
| 2 | $38.97 | 2,584 | $101K | 10.4% |
| 3 | $38.97 | 1,700 | $66K | 6.8% |
| 4 | $39.00 | 1,118 | $44K | 4.5% |
| 5 | $39.00 | 600 | $23K | 2.4% |
| 6 | $39.01 | 300 |
| $12K |
| 1.2% |
| 7 | $39.01 | 200 | $8K | 0.8% |
| 8 | $39.02 | 9,982 | $389K | 40.3% |
| Total | $39.26 avg | 24,636 | $967K | 100% |
| Filing → |
| ABT | SELL | 2016-03-02 | $474K | — | Filing → |
| ABT | SELL | 2015-03-12 | $627K | — | Filing → |
| ABT | SELL | 2014-01-31 | $414K | — | Filing → |